Results 161 to 170 of about 594 (209)

Hereditary angioedema plasma proteomics following specific plasma kallikrein inhibition with lanadelumab. [PDF]

Front Immunol
Sexton D, Kichev A, Juethner S, Yeung D, MacDonald A, Anokian E, Li B.   +6 more
europepmc   +1 more source

Lanadelumab safety, efficacy, and pharmacokinetics in patients aged ≥12 with hereditary angioedema in China: an open-label, multicenter study. [PDF]

Front Immunol
Zhi Y, Zhu R, Sun Y, Lai H, Ren H, Wang Y, Dong L.   +6 more
europepmc   +1 more source

Incidence of loiasis clinical manifestations in a rural area of the Republic of Congo: Results from a longitudinal prospective study (the MorLo project). [PDF]

PLoS Negl Trop Dis
Campillo JT, Pakat-Pambou BM, Sahm B, Pion SDS, Hemilembolo MC, Lebredonchel E, Boussinesq M, Missamou F, Chesnais CB.   +8 more
europepmc   +1 more source

A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee. [PDF]

Front Immunol
Cancian M, Caballero T, Boccon-Gibod I, Buttgereit T, Cohn D, Eren E, Kiani-Alikhan S, Launay D, Mandelin J, Zanichelli A, Farkas H.   +10 more
europepmc   +1 more source

Functional physiological, psychological, and biochemical reactivity to socially evaluated cold pressor test in hereditary angioedema patients (FRoSEn). [PDF]

Front Immunol
De Maria B, Ranucci L, Gino C, Cesoni Marcelli A, Zingale LC, Zulueta A, Dalla Vecchia LA, Gorini A, Perego F.   +8 more
europepmc   +1 more source

Burden of hereditary angioedema: results from a multinational survey of caregivers for adult and pediatric patients. [PDF]

Orphanet J Rare Dis
Watt M, Martinez-Saguer I, Simon A, Murphy R, De La Cruz M, Zwiener R, Sarrazola M, Grumach AS.   +7 more
europepmc   +1 more source

Exposure-Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema. [PDF]

Clin Transl Sci
Singh P, Witjes H, Kleijn HJ, Diep JK, Bordone L, Newman KB, Gao X, Cohn DM.   +7 more
europepmc   +1 more source

Analysis of prodromal symptoms and need for short-term prophylaxis in angioedema patients under long-term prophylaxis. [PDF]

Orphanet J Rare Dis
Lochbaum R, Hoffmann TK, Greve J, Hahn J.   +3 more
europepmc   +1 more source

Patient-Reported Outcomes in the Phase III OASIS-HAE Study of Donidalorsen for Hereditary Angioedema. [PDF]

Allergy
Riedl MA, Yarlas A, Bordone L, Treadwell S, Wang S, Newman KB, Cohn DM.   +6 more
europepmc   +1 more source

Hereditary angioedema due to C1-inhibitor deficiency: current therapeutic approaches. [PDF]

Curr Opin Allergy Clin Immunol
Costanzo G, Sambugaro G, Firinu D.
europepmc   +1 more source